A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

Congenital heart disease (CHD) is one of the most common birth defects, but the full extent of its genetic underpinnings has ...

According to the company’s U.S. privacy statement, if 23andMe is involved in a “bankruptcy, merger, acquisition, reorganization, or sale of assets, your Personal Information may be accessed, sold or ...

A gene variant common in Oceanian communities has been misclassified as a potential cause of heart disease, highlighting the ...

A test for abnormal fetal chromosomes can also detect maternal cancers—and physicians are struggling to incorporate that ...

Me filed for bankruptcy on Sunday, hit by faltering demand for its ancestry testing kits as it struggled to contain the ...

Studies conducted in human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) compared various cassette configurations and informed the final design of TN-201, which incorporates a ...

23andMe cofounder and CEO Anne Wojcicki stepped down and the company filed for Chapter 11 bankruptcy protection, it said Sunday, capping a year-long saga that saw Wojcicki fail to convince her own ...

A pioneering screening trial, recently announced at the Bethesda Lyceum, aims to transform community health by providing ...

Coronary artery disease, a collective term for angina and heart attacks, is among the most common causes of death among women ...

Since most cases of dementia are caused by a complex mixture of factors, the NHS only offers genetic testing in rare, specific circumstances. Genetic tests can be used to tell whether someone has ...

As Baylor Genetics celebrates a decade of leadership at the forefront of genetic testing, it is set to exhibit its latest scientific studies in genetic testing at the 2025 ACMG Annual Clinical ...